Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that’s 25 years of bringing you fearless, independent journalism. Since our first broadcast in 1996, Democracy Now! has refused to take corporate or government funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. If everyone who tunes in to Democracy Now! gave just $4, we could cover our operating expenses for the entire year. Really, that’s all it would take. Today, for Giving Tuesday, a generous donor will TRIPLE your donation, making it three times as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


WTO to Start Negotiations on COVID Vaccine Patent Waivers, 8 Months After They Were Proposed

HeadlineJun 10, 2021

World Trade Organization members have agreed to begin negotiations next week on a temporary waiver of intellectual property rights for coronavirus vaccines. South Africa and India first proposed the patent waivers in October of 2020 as part of an urgent effort to increase the availability of vaccines in poorer countries. The effort has languished for more than eight months amid opposition from pharmaceutical companies and wealthy WTO members. Since then, the world has recorded over 2.6 million COVID deaths and 140 million new infections. On Wednesday, Argentine President Alberto Fernández and Spanish Prime Minister Pedro Sánchez said in a joint news conference that they support a waiver for COVID vaccine patents. This is Prime Minister Sánchez.

Prime Minister Pedro Sánchez: “Argentina and Spain are defending the liberation of vaccines, making them a global public good and, consequently, speeding up their distribution and increasing their production capacity for the whole of humanity to vaccinate all of our societies as quickly as possible and overcome this calamity that COVID-19 represents.”

The Biden administration initially opposed patent waivers for COVID vaccines, then reversed course in May amid intense pressure from advocacy groups and some Democrats. The European Union and several nations, including the U.K. and Switzerland, remain opposed.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation